mebendazole has been researched along with Hepatitis B Virus Infection in 1 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, J | 1 |
| Fu, LL | 1 |
| Tian, M | 1 |
| Liu, HQ | 1 |
| Li, JJ | 1 |
| Li, Y | 1 |
| He, J | 1 |
| Huang, J | 1 |
| Ouyang, L | 1 |
| Gao, HY | 1 |
| Wang, JH | 1 |
1 other study available for mebendazole and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Design and synthesis of a novel candidate compound NTI-007 targeting sodium taurocholate cotransporting polypeptide [NTCP]-APOA1-HBx-Beclin1-mediated autophagic pathway in HBV therapy.
Topics: Antiviral Agents; Apolipoproteins B; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cell Line, | 2015 |